Epizyme to Participate in Wedbush 2012 Life Sciences: Management Access Conference
09:00 EDT 1 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Epizyme,
Inc., a company leading the creation of a new class of personalized
therapeutics for patients with genetically defined cancers, today
announced its participation in the Wedbush
2012 Life Sciences: Management Acce...
Other Sources for this Article
MacDougall Biomedical Communications
Kari Watson or Jennifer
Conrad, 781-235-3060
More From BioPortfolio on "Epizyme to Participate in Wedbush 2012 Life Sciences: Management Access Conference"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
